» Articles » PMID: 27519178

Portal Hypertensive Gastropathy As a Prognostic Index in Patients with Liver Cirrhosis

Overview
Publisher Biomed Central
Specialty Gastroenterology
Date 2016 Aug 14
PMID 27519178
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Portal hypertensive gastropathy (PHG) is a frequently overlooked complication of liver cirrhosis (LC). The clinical implications of PHG as a prognostic factor of LC or a predictive factor for the development of hepatocellular carcinoma (HCC) have not been established. The aim of this study was to assess the clinical significance of PHG in patients with LC.

Methods: Patients with LC were prospectively enrolled and followed in a single tertiary hospital in the Republic of Korea. Baseline hepatic vein pressure gradient (HVPG) was measured, and esophagogastroduodenoscopy (EGD) was performed. The associations of PHG with HVPG, survival and the development of HCC were evaluated.

Results: A total of 587 patients were enrolled. The mortality rate was 20.3 % (n = 119), and HCC developed in 9.2 % (n = 54) during the follow-up period (32.6 ± 27.8 months). The grade of PHG was well correlated with HVPG (no PGH: median 9.2 [IQR: 7.2-16.7], mild PHG: 14.6 [10.1-19.3], and severe PHG: 17.3 [12.3-21.5], P < 0.001), as well as with Child-Pugh class, MELD score or survival. However, it was not associated with the development of HCC. The grade of PHG (HR 3.29, 95 % CI: 1.12-9.63, severe vs. no PHG) and Child-Pugh class (HR 3.53, 95 % CI: 1.79-6.97, Child C vs A) showed significant associations with mortality.

Conclusion: PHG was well correlated with portal hypertension and could be used as a prognostic factor for LC but not for the prediction of HCC.

Citing Articles

A Nomogram for Predicting Portal Hypertensive Gastropathy in Patients With Liver Cirrhosis: A Retrospective Analysis.

Wang W, Mu Z, Zhu G, Wang T, Lai S, Guo Y Front Med (Lausanne). 2022; 9:834159.

PMID: 35252265 PMC: 8894675. DOI: 10.3389/fmed.2022.834159.


Quantification of gastric mucosal microcirculation as a surrogate marker of portal hypertension by spatially resolved subdiffuse reflectance spectroscopy in diagnosis of cirrhosis: a proof-of-concept study.

Mohanty A, Eshein A, Kamineni P, Avissar U, Bliss C, Long M Gastrointest Endosc. 2021; 94(1):60-67.e1.

PMID: 33385462 PMC: 8546777. DOI: 10.1016/j.gie.2020.12.037.


Portal hypertensive gastropathy is associated with iron deficiency anemia.

Simbrunner B, Beer A, Woran K, Schmitz F, Primas C, Wewalka M Wien Klin Wochenschr. 2020; 132(1-2):1-11.

PMID: 31912289 PMC: 6978296. DOI: 10.1007/s00508-019-01593-w.


Prevalence of Portal Hypertensive Gastropathy in Chronic Liver Disease and Correlation with the Severity of Liver disease.

Tiwari P, Kc S, Sharma D, Paudel M, Mandal A Cureus. 2019; 11(8):e5454.

PMID: 31641555 PMC: 6802813. DOI: 10.7759/cureus.5454.


Clinically Evident Portal Hypertension: An Operational Research Definition for Future Investigations in the Pediatric Population.

Bass L, Shneider B, Henn L, Goodrich N, Magee J J Pediatr Gastroenterol Nutr. 2019; 68(6):763-767.

PMID: 30908382 PMC: 6534459. DOI: 10.1097/MPG.0000000000002333.


References
1.
Kamath P, Lacerda M, Ahlquist D, McKusick M, Andrews J, Nagorney D . Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology. 2000; 118(5):905-11. DOI: 10.1016/s0016-5085(00)70176-4. View

2.
Garcia-Tsao G, Friedman S, Iredale J, Pinzani M . Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology. 2010; 51(4):1445-9. PMC: 2882065. DOI: 10.1002/hep.23478. View

3.
Pinzone M, Zanghi A, Rapisarda L, DAgata V, Benanti F, Sparta D . Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response. Eur Rev Med Pharmacol Sci. 2014; 18(2 Suppl):11-5. View

4.
Abbasi A, Bhutto A, Butt N, Munir S, Dhillo A . Frequency of portal hypertensive gastropathy and its relationship with biochemical, haematological and endoscopic features in cirrhosis. J Coll Physicians Surg Pak. 2011; 21(12):723-6. DOI: 12.2011/JCPSP.723726. View

5.
Ohta M, Hashizume M, Higashi H, Ueno K, Tomikawa M, Kishihara F . Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology. 1994; 20(6):1432-6. DOI: 10.1002/hep.1840200609. View